Sana Pharma Medical
Sana Pharma Medical, headquartered in Norway, is a leading player in the pharmaceutical industry, specialising in innovative medical solutions. Founded in 2015, the company has rapidly expanded its operations across Europe, focusing on the development and distribution of high-quality pharmaceuticals and medical devices. Sana Pharma Medical is renowned for its commitment to research and development, offering a unique portfolio of products that cater to various therapeutic areas. Their core services include the provision of advanced drug delivery systems and tailored healthcare solutions, setting them apart in a competitive market. With a strong emphasis on quality and efficacy, Sana Pharma Medical has achieved significant milestones, establishing itself as a trusted name in the industry. Their dedication to improving patient outcomes continues to drive their success and market position.
DitchCarbon Score
How does Sana Pharma Medical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Sana Pharma Medical's score of 21 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Sana Pharma Medical's reported carbon emissions
Sana Pharma Medical, headquartered in Norway, currently does not have available carbon emissions data for the most recent year. As a result, specific figures regarding their emissions in kg CO2e, including Scope 1, 2, or 3 emissions, are not provided. In the absence of concrete emissions data, it is important to note that Sana Pharma Medical has not outlined any specific reduction targets or initiatives related to carbon emissions. Furthermore, there are no commitments to the Science Based Targets initiative (SBTi) or any climate pledges mentioned. As the pharmaceutical industry increasingly focuses on sustainability and reducing carbon footprints, it is essential for companies like Sana Pharma Medical to establish clear climate commitments and reduction strategies to align with global climate goals.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Sana Pharma Medical is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
